Search research articles
Contact Us
Filters
Showing results (11-20 of 12) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 12 results.
The American Journal of Cardiology
|
September 10, 2017
Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
Sean T Chen, Anne S Hellkamp, Richard C Becker, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
September 17, 2018
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF
Sean T Chen, Anne S Hellkamp, Richard C Becker, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 12) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 12 results.
The American Journal of Cardiology
|
September 10, 2017
Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
Sean T Chen, Anne S Hellkamp, Richard C Becker, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
September 17, 2018
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF
Sean T Chen, Anne S Hellkamp, Richard C Becker, et al.
Page
of 2